| Literature DB >> 25108703 |
Barbara Pacholczyk-Sienicka1, Maciej Radek, Andrzej Radek, Stefan Jankowski.
Abstract
OBJECT: The objective of this study is the identification of metabolites by means of (1)H high resolution magic angle spinning nuclear magnetic resonance ((1)H HR MAS NMR) spectroscopy and the evaluation of their applicability in distinguishing between healthy and degenerated disc tissues.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25108703 PMCID: PMC4385564 DOI: 10.1007/s10334-014-0457-0
Source DB: PubMed Journal: MAGMA ISSN: 0968-5243 Impact factor: 2.310
Fig. 1Representative ex vivo 1H HR MAS NMR spectra of a healthy disc (a), and of a degenerated disc for the aliphatic (b) and aromatic (c) regions of the spectrum
Metabolites assigned in HR MAS spectra of disc tissues, their diagnostic 1H signals, chemical shifts (δ H) and multiplicities
| Assignment number | Metabolite | Assignment | 1H multiplicity |
|
|---|---|---|---|---|
| 1 | Acetate | CH3 | s | 1.93 |
| 2 | Acetone | CH3 | s | 2.23 |
| 3 | Alanine | CH3 | d | 1.48 |
| CH | q | 3.78 | ||
| 4 | Aspartate | β-CH2 | dd, dd | 2.67, 2.81 |
| α-CH | dd | 3.91 | ||
| 5 | Chondroitin sulfate |
| s | 2.05 |
| 6 | Citric acid | CH2 | d | 2.54 |
| CH2 | d | 2.66 | ||
| 7 | Creatine | CH3 | s | 3.03 |
| CH2 | s | 3.93 | ||
| 8 | Fatty acids | CH3 | t | 0.90 |
| (CH2)n | m | 1.29 | ||
| CH2–CH2–CO | q | 1.55 | ||
| 9 | Formate | s | 8.45 | |
| 10 | Glycine | α-CH2 | s | 3.55 |
| 11 | α-Glucose | C4H | 3.40 | |
| C2H | dd | 3.54 | ||
| C3H | dd | 3.71 | ||
| C6H | 3.83 | |||
| C5H | 3.85 | |||
| C1H | d | 5.23 | ||
| 12 | β-Glucose | C2H | dd | 3.24 |
| C4H | 3.41 | |||
| C5H | dd | 3.46 | ||
| C3H | t | 3.49 | ||
| C6H | t | 3.76 | ||
| C6′H | dd | 3.90 | ||
| C1H | d | 4.64 | ||
| 13 | Histidine | C2H, ring | s | 7.05 |
| C4H,ring | s | 7.75 | ||
| 14 | Hydroxyproline | β-CH | m | 2.13 |
| β′-CH | m | 2.36 | ||
| δ-CH | dt | 3.35 | ||
| δ′-CH | dd | 3.42 | ||
| α-CH | dd | 4.26 | ||
| γ-CH | t | 4.67 | ||
| 15 | Isoleucine | δ-CH3 | t | 0.94 |
| γ-CH3 | d | 1.01 | ||
| γ-CH2 | m | 1.27–1.47 | ||
| β-CH | m | 1.98 | ||
| α-CH | d | 3.67 | ||
| 16 | Lactate | CH3 | d | 1.33 |
| CH | q | 4.11 | ||
| 17 | Leucine | δ-CH3 | d | 0.96 |
| δ-CH3 | d | 0.97 | ||
| γ-CH | m | 1.70 | ||
| β-CH2 | m | 1.72 | ||
| α-CH | m | 3.74 | ||
| 18 | Lysine | δ-CH2 | m | 1.41 |
| γ-CH2 | m | 1.67 | ||
| β-CH2 | m | 1.70 | ||
| ε-CH2 | t | 3.02 | ||
| α-CH | t | 3.77 | ||
| 19 |
| C5H | t | 3.27 |
| C1H, C3H | dd | 3.53 | ||
| C4H, C6H | t | 3.62 | ||
| C2H | t | 4.06 | ||
| 20 | Phenylalanine | β-CH | dd | 3.21 |
| α-CH | dd | 3.97 | ||
| C2H, C6H, ring | m | 7.33 | ||
| C4H, ring | m | 7.38 | ||
| C3H, C5H, ring | m | 7.43 | ||
| 21 | 2-Propanol | CH3 | d | 1.17 |
| CH | sp | 4.02 | ||
| 22 |
| CH | s | 3.35 |
| 23 | Taurine | S-CH2 | t | 3.29 |
| N-CH2 | t | 3.43 | ||
| 24 | Tyrosine | β-CH | dd | 3.20 |
| β′-CH | dd | 3.05 | ||
| α-CH | dd | 3.94 | ||
| C3H, C5H, ring | d | 6.91 | ||
| C2H, C6H, ring | d | 7.19 | ||
| 25 | Uracil | 5-CH, ring | d | 5.80 |
| 6-CH, ring | d | 7.53 | ||
| 26 | Valine | γ-CH3 | d | 1.00 |
| γ-CH3 | d | 1.04 | ||
| β-CH | m | 2.27 | ||
| α-CH | d | 3.61 |
Notation: s singlet, d dublet, dd dublet of dublets, t triplet, dt dublet of triplets, sp septet, q quartet, m multiplet
Fig. 2Relationship between patient age and the concentrations of 2-propanol, lactate, and alanine in the annulus fibrosus of degenerated discs
Fig. 3Relationship between age and the concentrations of 2-propanol, lactate, and alanine in the nucleus pulposus of degenerated discs
Fig. 4Concentrations of metabolites in degenerated discs and the control group. Other metabolites are reported as Supplementary material in Tables SM1–SM3 and Figure SM2
Fig. 5A score plot of PC1 versus PC2 versus PC3 and a loading plot of PC1 from PCA of spin-echo spectra from patients diagnosed with intervertebral disc degeneration (circles) and from healthy samples (squares)